EP0031
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EP0031, covering 2026-02-03 to 2026-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of EP0031 in Patients With Advanced RET-altered Malignancies [Phase 1, Phase 2]